Advertisement AxoGen forms alliance with Stryker Orthopaedics for Avance grafts - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

AxoGen forms alliance with Stryker Orthopaedics for Avance grafts

AxoGen has signed an exclusive agreement with Stryker Orthopaedics to provide distribution and co-marketing services for the new Avance Nerve Graft.

Stryker will be responsible for Avance Nerve Graft distribution services for nerve repairs in the upper extremities, lower extremities and brachial plexus. AxoGen will provide distribution services within the head, neck and torso. Avance Nerve Graft is intended for use in the repair of damaged and diseased peripheral nerves.

John Engels, vice president for AxoGen, said: “AxoGen is pleased to be partnering with Stryker to bring hope of restoration of nerve function to more patients suffering from peripheral nerve damage and disease. This partnership represents a milestone achievement for our organization.”